Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100

Background: Subsets of CD4+ T-cells have been proposed to serve differential roles in the development of atherosclerosis. Some T-cell types are atherogenic (T-helper type 1), while others are thought to be protective (regulatory T-cells). Lineage commitment toward one type of helper T-cell versus an...

Full description

Bibliographic Details
Main Authors: Kevin Yee-Bien Tse, Ayelet eGonen, John eSidney, Hui eOuyang, Joseph L Witztum, Alessandro eSette, Harley Y Tse, Klaus eLey
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00493/full
id doaj-ae5dc9697b3e49c0a98abb802771866c
record_format Article
spelling doaj-ae5dc9697b3e49c0a98abb802771866c2020-11-24T23:27:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242013-12-01410.3389/fimmu.2013.0049374978Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100Kevin Yee-Bien Tse0Ayelet eGonen1John eSidney2Hui eOuyang3Joseph L Witztum4Alessandro eSette5Harley Y Tse6Klaus eLey7University of California at San DiegoUniversity of California at San DiegoLa Jolla Institute for Allergy and ImmunologyLa Jolla Institute for Allergy and ImmunologyUniversity of California at San DiegoLa Jolla Institute for Allergy and ImmunologyWayne State UniversityLa Jolla Institute for Allergy and ImmunologyBackground: Subsets of CD4+ T-cells have been proposed to serve differential roles in the development of atherosclerosis. Some T-cell types are atherogenic (T-helper type 1), while others are thought to be protective (regulatory T-cells). Lineage commitment toward one type of helper T-cell versus another is strongly influenced by the inflammatory context in which antigens are recognized. Immunization of atherosclerosis-prone mice with low density lipoprotein (LDL) or its oxidized derivative (ox-LDL) is known to be atheroprotective. However, the antigen specificity of the T-cells induced by vaccination and the mechanism of protection are not known.<br/>Methods: Identification of two peptide fragments (ApoB3501-3516 and ApoB978-993) from murine ApoB-100 was facilitated using I-Ab prediction models, and their binding to I-Ab determined. Utilizing a vaccination scheme based on complete and incomplete Freund’s adjuvant (1x CFA + 4x IFA), we immunized Apoe-/- mice with ApoB3501-3516 or ApoB978-993 emulsified in CFA once and subsequently boosted in IFA four times over 15 weeks. Spleens, lymph nodes and aortas were harvested and evaluated by flow cytometry and real time RT-PCR. Total atherosclerotic plaque burden was determined by aortic pinning and by aortic root histology.<br/>Results: Mice immunized with ApoB3501-3516 or ApoB978-993 demonstrated 40% reduction in overall plaque burden when compared to adjuvant only control mice. Aortic root frozen sections from ApoB3501-3516 immunized mice showed a >60% reduction in aortic sinus plaque development. Aortas from both ApoB3501-3516 and ApoB978-993 immunized mice contained significantly more mRNA for IL-10. Both antigen-specific IgG1 and IgG2c titers were elevated in ApoB3501-3516 or ApoB978-993 immunized mice, suggesting helper T-cell immune activity after immunization.<br/>Conclusion: Our data show that MHC Class II restricted ApoB-100 peptides can be atheroprotective, potentially through a mechanism involving elevated IL-10.http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00493/fullAtherosclerosisVaccinationIL-10T-cellsApoB-100 Peptides
collection DOAJ
language English
format Article
sources DOAJ
author Kevin Yee-Bien Tse
Ayelet eGonen
John eSidney
Hui eOuyang
Joseph L Witztum
Alessandro eSette
Harley Y Tse
Klaus eLey
spellingShingle Kevin Yee-Bien Tse
Ayelet eGonen
John eSidney
Hui eOuyang
Joseph L Witztum
Alessandro eSette
Harley Y Tse
Klaus eLey
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
Frontiers in Immunology
Atherosclerosis
Vaccination
IL-10
T-cells
ApoB-100 Peptides
author_facet Kevin Yee-Bien Tse
Ayelet eGonen
John eSidney
Hui eOuyang
Joseph L Witztum
Alessandro eSette
Harley Y Tse
Klaus eLey
author_sort Kevin Yee-Bien Tse
title Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
title_short Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
title_full Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
title_fullStr Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
title_full_unstemmed Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
title_sort atheroprotective vaccination with mhc-ii restricted peptides from apob-100
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2013-12-01
description Background: Subsets of CD4+ T-cells have been proposed to serve differential roles in the development of atherosclerosis. Some T-cell types are atherogenic (T-helper type 1), while others are thought to be protective (regulatory T-cells). Lineage commitment toward one type of helper T-cell versus another is strongly influenced by the inflammatory context in which antigens are recognized. Immunization of atherosclerosis-prone mice with low density lipoprotein (LDL) or its oxidized derivative (ox-LDL) is known to be atheroprotective. However, the antigen specificity of the T-cells induced by vaccination and the mechanism of protection are not known.<br/>Methods: Identification of two peptide fragments (ApoB3501-3516 and ApoB978-993) from murine ApoB-100 was facilitated using I-Ab prediction models, and their binding to I-Ab determined. Utilizing a vaccination scheme based on complete and incomplete Freund’s adjuvant (1x CFA + 4x IFA), we immunized Apoe-/- mice with ApoB3501-3516 or ApoB978-993 emulsified in CFA once and subsequently boosted in IFA four times over 15 weeks. Spleens, lymph nodes and aortas were harvested and evaluated by flow cytometry and real time RT-PCR. Total atherosclerotic plaque burden was determined by aortic pinning and by aortic root histology.<br/>Results: Mice immunized with ApoB3501-3516 or ApoB978-993 demonstrated 40% reduction in overall plaque burden when compared to adjuvant only control mice. Aortic root frozen sections from ApoB3501-3516 immunized mice showed a >60% reduction in aortic sinus plaque development. Aortas from both ApoB3501-3516 and ApoB978-993 immunized mice contained significantly more mRNA for IL-10. Both antigen-specific IgG1 and IgG2c titers were elevated in ApoB3501-3516 or ApoB978-993 immunized mice, suggesting helper T-cell immune activity after immunization.<br/>Conclusion: Our data show that MHC Class II restricted ApoB-100 peptides can be atheroprotective, potentially through a mechanism involving elevated IL-10.
topic Atherosclerosis
Vaccination
IL-10
T-cells
ApoB-100 Peptides
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00493/full
work_keys_str_mv AT kevinyeebientse atheroprotectivevaccinationwithmhciirestrictedpeptidesfromapob100
AT ayeletegonen atheroprotectivevaccinationwithmhciirestrictedpeptidesfromapob100
AT johnesidney atheroprotectivevaccinationwithmhciirestrictedpeptidesfromapob100
AT huieouyang atheroprotectivevaccinationwithmhciirestrictedpeptidesfromapob100
AT josephlwitztum atheroprotectivevaccinationwithmhciirestrictedpeptidesfromapob100
AT alessandroesette atheroprotectivevaccinationwithmhciirestrictedpeptidesfromapob100
AT harleyytse atheroprotectivevaccinationwithmhciirestrictedpeptidesfromapob100
AT klauseley atheroprotectivevaccinationwithmhciirestrictedpeptidesfromapob100
_version_ 1725551554486861824